Sino Biopharmaceutical

Sino Biopharmaceutical is a leading Chinese innovative research and R&D-driven pharmaceutical group

Sino Biopharmaceutical, founded in 2020 and headquartered in Hong Kong, is the leading innovative research and R&D-driven pharmaceutical group in China, with a business scope that covers the entire industry chain of pharmaceutical R&D platforms, intelligent production, and strong sales systems. Established by Xie Qirun, it was listed on the Hong Kong Stock Exchange In September of the same year as the foundation. The company's major shareholders are Thousand Eagles Limited, FRANCE INVESTMENT (CHINA 1) GROUP LIMITED, Remarkable Industries Limited, and Validated Profits Limited. Rivals with the direct and indirect competition with Sino Biopharmaceutical include Lansen Pharmaceutical, Chia Tai Enterprises, Hansoh Pharma.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Large Pharma

Founded

Apr 5, 2000

HQ location

HongKong, China

Legal name

Sino Biopharmaceutical Co., Ltd.

Employees

21514

See more